Joseph Lewis's Net Worth
$13.8 Billion
Who is Joseph Lewis?
Joseph Lewis has an estimated net worth of $13.8 Billion. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., SOPHIRIS BIO INC., iTeos Therapeutics, Inc., PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., Tyra Biosciences, Inc., Tango Therapeutics, Inc., INSEEGO CORP., Esperion Therapeutics, Inc., Solid Biosciences Inc., Eleven Biotherapeutics, Inc., Pandion Therapeutics, Inc., Rain Oncology Inc., Somaxon Pharmaceuticals, Inc., ARADIGM CORP, and BAYCORP HOLDINGS LTD.
SEC CIK
Joseph Lewis's CIK is 0001015747
Past Insider Trading and Trends
2020 was Joseph Lewis's most active year for acquiring shares with 25 total transactions. Joseph Lewis's most active month to acquire stocks was the month of September. 2020 was Joseph Lewis's most active year for disposing of shares, totalling 45 transactions. Joseph Lewis's most active month to dispose stocks was the month of September. 2023 saw Joseph Lewis paying a total of $116,443,894.38 for 10,864,621 shares, this is the most they've acquired in one year. In 2020 Joseph Lewis cashed out on 19,927,835 shares for a total of $168,684,272.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3210
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.68% | -400.00K |
$1.56 | -$623,340.00 | 4.21M |
Nov 22 - Nov 24
| |||
Form 4
| -17.83% | -1.00M |
$2.06 | -$2,062,775.00 | 4.61M |
Nov 17 - Nov 19
| |||
Form 4
| +7.68% | 400K |
$17.16 | $6,863,427.50 | 5.61M |
Dec 28 - Dec 30
| |||
Form 4
| +4.31% | 215.2K |
$13.63 | $2,932,156.00 | 5.21M |
Sep 28 - Sep 29
| |||
Form 4
| +4.72% | 225K |
$14.99 | $3,371,631.00 | 4.99M |
Sep 4 - Sep 9
| |||
Form 4
| +41.73% | 1.4M |
$14.25 | $20,000,003.25 | 4.77M |
Aug 28
| |||
Form 4
| +4.38% | 125K |
$13.27 | $1,658,830.00 | 2.98M |
Dec 21 - Dec 26
| |||
Form 4
| +0.95% | 26.82K |
$14.72 | $394,752.71 | 2.85M |
Oct 24
| |||
Form 4
| +3.67% | 100K |
$22.73 | $2,273,153.36 | 2.83M |
Mar 22 - Mar 26
| |||
Form 4
| +18.04% | 416.67K |
$24.00 | $9,999,984.00 | 2.73M |
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOPHIRIS BIO INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -34.41% | -881.48K |
$0.61 | -$537,702.19 | 1.68M |
Dec 15
| |||
Form 4
| +166.40% | 1.6M |
$5.00 | $8,000,000.00 | 2.56M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.35% | 1.14M |
$17.50 | $19,999,997.50 | 2.95M |
May 10
| |||
Form 4
| -16.25% | -350.00K |
$16.26 | -$5,692,672.88 | 1.8M |
Aug 23
| |||
Form 4
| -15.47% | -575.20K |
$35.25 | -$20,275,835.25 | 3.14M |
Mar 17
| |||
Form 4
| -8.41% | -700.00K |
$45.32 | -$32,575,642.35 | 7.62M |
Jan 3 - Jan 4
| |||
Form 4
| +147.62% | 4.42M |
$19.00 | $27,075,000.00 | 7.41M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.33M |
$18.00 |
—
| 2.33M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.86M |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
|
—
|
0
|
$197.64 | -$2,446,911.13 | 3.14M |
Mar 9 - Mar 10
| |||
Form 4
| +10.47% | 211.44K |
$181.15 | -$72,460,293.56 | 2.23M |
Mar 5
| |||
Form 4
|
—
|
0
|
$207.99 | -$80,800,259.91 | 3.42M |
Oct 30
| |||
Form 4
|
—
|
0
|
$208.34 | -$83,334,657.83 | 3.14M |
Oct 28 - Oct 29
| |||
Form 4
| +14.07% | 193.05K |
$38.85 | $7,499,992.50 | 1.57M |
Jun 7
| |||
Form 4
| +18.19% | 267.97K |
$7.86 | $2,106,212.76 | 1.74M |
Oct 3
| |||
Form 4
| +24.10% | 286.16K |
$5.60 | $1,602,512.80 | 1.47M |
Jan 6
| |||
Form 4
| -100.00% | -522.50K |
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.80% | 45K |
$45.00 | $2,025,000.00 | 2.55M |
Sep 16 - Sep 17
| |||
Form 4
| +28.19% | 550K |
$20.00 | $11,000,000.00 | 2.5M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +20.20% | 400K |
$17.50 | $7,000,000.00 | 2.38M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||